BRAIDWELL LP
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
82 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $2,616,195,636 |
| Financial Services | 0.3% | $9,144,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | +2,258,258 | 3,206,574 | $52,748,142 | |
| MRVI | Maravai Lifesciences Holdings, Inc. | +1,886,877 | 10,240,164 | $28,979,664 | |
| NEO | Neogenomics Inc | +984,601 | 5,617,402 | $41,681,122 | |
| ZURA | Zura Bio Ltd | +808,600 | 3,988,989 | $23,734,484 | |
| CDNA | CareDx, Inc. | +587,926 | 2,173,146 | $37,725,814 | |
| MBX | MBX Biosciences, Inc. | +473,867 | 1,492,467 | $44,550,139 | |
| ACAD | Acadia Pharmaceuticals Inc | +439,178 | 2,471,199 | $55,008,889 | |
| IRTC | iRhythm Holdings, Inc. | +392,847 | 610,192 | $72,014,859 | |
| DRUG | Bright Minds Biosciences Inc. | +215,350 | 539,708 | $39,382,492 | |
| DYN | Dyne Therapeutics, Inc. | +203,669 | 1,681,998 | $30,494,623 | |
| CAI | Caris Life Sciences, Inc. | +193,305 | 8,009,447 | $143,208,912 | |
| HNGE | Hinge Health, Inc. | +150,500 | 1,455,123 | $56,109,542 | |
| INSP | Inspire Medical Systems, Inc. | +136,680 | 677,570 | $34,949,060 | |
| FULC | Fulcrum Therapeutics, Inc. | +73,700 | 3,134,922 | $24,044,851 | |
| ARGX | Argenx SE | +53,932 | 84,939 | $62,026,704 | |
| DHR | Danaher Corp /De/ | +21,100 | 139,327 | $26,416,399 | |
| NTRA | Natera, Inc. | +17,500 | 129,000 | $25,798,710 | |
| TMDX | TransMedics Group, Inc. | +14,050 | 329,391 | $32,744,759 | |
| TMO | Thermo Fisher Scientific Inc. | +12,190 | 92,915 | $45,670,509 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | −2,863,248 | 2,347,583 | $73,948,864 | |
| CGON | CG Oncology, Inc. | −885,788 | 984,783 | $66,650,113 | |
| CMPX | Compass Therapeutics, Inc. | −821,672 | 1,965,106 | $10,395,410 | |
| SYRE | Spyre Therapeutics, Inc. | −701,792 | 932,823 | $47,051,592 | |
| ENGN | enGene Therapeutics Inc. | −674,449 | 2,456,870 | $16,731,284 | |
| CLDX | Celldex Therapeutics, Inc. | −502,027 | 1,356,082 | $43,014,921 | |
| XENE | Xenon Pharmaceuticals Inc. | −486,624 | 1,338,452 | $77,830,983 | |
| NRIX | Nurix Therapeutics, Inc. | −433,098 | 1,750,766 | $27,136,873 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −374,571 | 899,364 | $75,474,626 | |
| CVS | CVS HEALTH Corp | −273,500 | 290,700 | $20,878,074 | |
| VERA | Vera Therapeutics, Inc. | −260,918 | 523,824 | $21,073,439 | |
| KOD | Kodiak Sciences Inc. | −254,123 | 1,818,665 | $69,327,509 | |
| SLNO | Soleno Therapeutics Inc | −228,600 | 959,259 | $32,115,991 | |
| CNTA | Centessa Pharmaceuticals plc | −201,552 | 1,986,768 | $78,914,424 | |
| BTSG | BrightSpring Health Services, Inc. | −179,224 | 1,016,562 | $43,315,706 | |
| GKOS | GLAUKOS Corp | −158,474 | 763,505 | $82,198,948 | |
| HROW | Harrow, Inc. | −138,872 | 156,419 | $5,515,333 | |
| NUVL | Nuvalent, Inc. | −120,977 | 700,429 | $71,758,951 | |
| KYMR | Kymera Therapeutics, Inc. | −116,700 | 337,559 | $28,115,289 | |
| BMRN | Biomarin Pharmaceutical Inc | −104,500 | 497,020 | $28,076,659 | |
| NBIX | Neurocrine Biosciences Inc | −99,413 | 652,121 | $85,910,420 | |
| APGE | Apogee Therapeutics, Inc. | −96,400 | 478,667 | $40,289,401 | |
| XFOR | X4 Pharmaceuticals, Inc | −95,950 | 3,272,954 | $13,517,300 | |
| TECX | Tectonic Therapeutic, Inc. | −80,373 | 847,151 | $26,185,437 | |
| SRZN | Surrozen, Inc./DE | −73,900 | 396,100 | $11,538,393 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GH | Guardant Health, Inc. | 499,712 | $46,158,397 | |
| GENB | Generate Biomedicines, Inc. | 3,592,999 | $44,912,487 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 310,628 | $27,015,317 | |
| ESTA | Establishment Labs Holdings Inc. | 463,600 | $26,323,208 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 1,752,798 | $25,643,434 | |
| ATEC | Alphatec Holdings, Inc. | 2,172,725 | $23,639,248 | |
| DMRA | Damora Therapeutics, Inc. | 894,846 | $23,176,511 | |
| BSX | Boston Scientific Corp | 346,467 | $21,740,804 | |
| BIOA | BioAge Labs, Inc. | 1,200,587 | $20,998,266 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 265,715 | $18,639,907 | |
| ELV | Elevance Health, Inc. | 62,080 | $18,173,920 | |
| NKTR | Nektar Therapeutics | 222,701 | $16,023,336 | |
| ACHC | Acadia Healthcare Company, Inc. | 645,900 | $15,107,601 | |
| ORIC | Oric Pharmaceuticals, Inc. | 1,128,040 | $14,292,266 | |
| AVAH | Aveanna Healthcare Holdings, Inc. | 2,203,506 | $14,190,578 | |
| TGTX | Tg Therapeutics, Inc. | 358,800 | $11,919,336 | |
| CNC | Centene Corp | 330,000 | $10,804,200 | |
| CLYM | Climb Bio, Inc. | 1,529,675 | $10,478,273 | |
| IONS | Ionis Pharmaceuticals Inc | 130,862 | $9,826,427 | |
| HLXC | Helix Acquisition Corp. III | 900,000 | $9,144,000 | |
| VOR | Vor Biopharma Inc. | 466,774 | $8,327,248 | |
| RVMD | Revolution Medicines, Inc. | 84,900 | $8,256,525 | |
| ACRS | Aclaris Therapeutics, Inc. | 1,699,116 | $6,371,685 | |
| DNLI | Denali Therapeutics Inc. | 296,324 | $5,689,420 | |
| RVTY | Revvity, Inc. | 48,400 | $4,240,324 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALGN | Align Technology Inc | 381,004 | $59,493,774 | |
| LEGN | Legend Biotech Corp | 1,298,142 | $28,221,607 | |
| TERN | Terns Pharmaceuticals, Inc. | 575,321 | $23,242,968 | |
| BIIB | Biogen Inc. | 115,700 | $20,362,043 | |
| ICLR | Icon PLC | 73,370 | $13,369,481 | |
| RLMD | Relmada Therapeutics, Inc. | 1,582,257 | $7,642,301 | |
| XNCR | Xencor Inc | 459,166 | $7,029,831 | |
| CSTL | Castle Biosciences Inc | 177,183 | $6,892,418 | |
| BLLN | BillionToOne, Inc. | 50,000 | $4,092,000 | |
| ORKA | Oruka Therapeutics, Inc. | 84,795 | $2,570,136 | |
| KPTI | Karyopharm Therapeutics Inc. | 303,370 | $2,232,803 | |
| ADPT | Adaptive Biotechnologies Corp | 311,991 | $1,266,683 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Added | 8,009,447 | $143,208,912 | 5.45% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 652,121 | $85,910,420 | 3.27% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 763,505 | $82,198,948 | 3.13% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 1,986,768 | $78,914,424 | 3.01% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 1,338,452 | $77,830,983 | 2.96% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 899,364 | $75,474,626 | 2.87% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 2,347,583 | $73,948,864 | 2.82% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 610,192 | $72,014,859 | 2.74% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 700,429 | $71,758,951 | 2.73% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 1,818,665 | $69,327,509 | 2.64% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 984,783 | $66,650,113 | 2.54% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 84,939 | $62,026,704 | 2.36% | |
| HNGE |
Hinge Health, Inc.
Healthcare
|
Added | 1,455,123 | $56,109,542 | 2.14% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 2,471,199 | $55,008,889 | 2.10% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 3,206,574 | $52,748,142 | 2.01% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 182,425 | $47,124,026 | 1.79% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 932,823 | $47,051,592 | 1.79% | |
| GH |
Guardant Health, Inc.
Healthcare
|
NEW | 499,712 | $46,158,397 | 1.76% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 92,915 | $45,670,509 | 1.74% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
NEW | 3,592,999 | $44,912,487 | 1.71% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 1,492,467 | $44,550,139 | 1.70% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 1,016,562 | $43,315,706 | 1.65% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,356,082 | $43,014,921 | 1.64% | |
| NEO |
Neogenomics Inc
Healthcare
|
Added | 5,617,402 | $41,681,122 | 1.59% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 478,667 | $40,289,401 | 1.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 539,708 | $39,382,492 | 1.50% | |
| CDNA |
CareDx, Inc.
Healthcare
|
Added | 2,173,146 | $37,725,814 | 1.44% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 77,297 | $35,633,144 | 1.36% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Added | 677,570 | $34,949,060 | 1.33% | |
| PEN |
Penumbra Inc
Healthcare
|
Reduced | 105,352 | $34,594,436 | 1.32% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
Added | 329,391 | $32,744,759 | 1.25% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 959,259 | $32,115,991 | 1.22% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,681,998 | $30,494,623 | 1.16% | |
| MRVI |
Maravai Lifesciences Holdings, Inc.
Healthcare
|
Added | 10,240,164 | $28,979,664 | 1.10% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Reduced | 229,215 | $28,253,040 | 1.08% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 337,559 | $28,115,289 | 1.07% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 497,020 | $28,076,659 | 1.07% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 1,750,766 | $27,136,873 | 1.03% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 310,628 | $27,015,317 | 1.03% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 139,327 | $26,416,399 | 1.01% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
NEW | 463,600 | $26,323,208 | 1.00% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 847,151 | $26,185,437 | 1.00% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 129,000 | $25,798,710 | 0.98% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,752,798 | $25,643,434 | 0.98% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 3,134,922 | $24,044,851 | 0.92% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 3,988,989 | $23,734,484 | 0.90% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
NEW | 2,172,725 | $23,639,248 | 0.90% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 894,846 | $23,176,511 | 0.88% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 346,467 | $21,740,804 | 0.83% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 523,824 | $21,073,439 | 0.80% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.